Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib

BACKGROUND: Evidence suggests that both selective cyclooxygenase (COX)‐2 inhibitors and non‐selective non‐steroidal anti‐inflammatory drugs (NSAIDs) increase the risk of cardiovascular events. However, evidence from prospective studies of currently available COX‐2 inhibitors and non‐selective NSAIDs...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Farkouh, M E, Greenberg, J D, Jeger, R V, Ramanathan, K, Verheugt, F W A, Chesebro, J H, Kirshner, H, Hochman, J S, Lay, C L, Ruland, S, Mellein, B, Matchaba, P T, Fuster, V, Abramson, S B
Format: Artigo
Jezik:Inglês
Izdano: BMJ Group 2007
Teme:
Extended Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC1954641/
https://ncbi.nlm.nih.gov/pubmed/17412741
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2006.066001
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki